Cross-border reproductive care: an Ethics Committee opinion

Judith Daar; Jean Benward; Lee Rubin Collins; Joseph Davis; Leslie Franics; Elena Gates; Elizabeth Ginsburg; Sigal Klipstein; Barbara Koenig; Laurence McCullough; Richard Reindollar; Rebecca Sokol; Mark Sauer; Sean Tipton; Lynn Westphal

doi:10.1016/j.fertnstert.2016.08.038

Cross-border reproductive care: an Ethics Committee opinion

Judith Daar, Jean Benward, Lee Rubin Collins, Joseph Davis, Leslie Franics, Elena Gates, Elizabeth Ginsburg, Sigal Klipstein, Barbara Koenig, Laurence McCullough, Richard Reindollar, Rebecca Sokol, Mark Sauer, Sean Tipton, Lynn Westphal

Research output: Contribution to journal › Article › peer-review

33 Scopus citations

Abstract

Cross-border reproductive care (CBRC) is a growing worldwide phenomenon, raising questions about why assisted reproductive technology (ART) patients travel abroad, what harms and benefits may result, and what duties health-care providers may have in advising and treating patients who travel for reproductive services. Cross-border care offers benefits and poses harms to ART stakeholders, including patients, offspring, providers, gamete donors, gestational carriers, and local populations in destination countries. This document replaces the previous document of the same name, last published in 2013 (Fertil Steril 2013;100:645–50).

Original language	English (US)
Pages (from-to)	1627-1633
Number of pages	7
Journal	Fertility and Sterility
Volume	106
Issue number	7
DOIs	https://doi.org/10.1016/j.fertnstert.2016.08.038
State	Published - Dec 1 2016
Externally published	Yes

All Science Journal Classification (ASJC) codes

Reproductive Medicine
Obstetrics and Gynecology

Access to Document

10.1016/j.fertnstert.2016.08.038

Cite this

@article{8c8efb6dbe3d457f98eff2d5ee69c93b,

title = "Cross-border reproductive care: an Ethics Committee opinion",

abstract = "Cross-border reproductive care (CBRC) is a growing worldwide phenomenon, raising questions about why assisted reproductive technology (ART) patients travel abroad, what harms and benefits may result, and what duties health-care providers may have in advising and treating patients who travel for reproductive services. Cross-border care offers benefits and poses harms to ART stakeholders, including patients, offspring, providers, gamete donors, gestational carriers, and local populations in destination countries. This document replaces the previous document of the same name, last published in 2013 (Fertil Steril 2013;100:645–50).",

author = "Judith Daar and Jean Benward and Collins, {Lee Rubin} and Joseph Davis and Leslie Franics and Elena Gates and Elizabeth Ginsburg and Sigal Klipstein and Barbara Koenig and Laurence McCullough and Richard Reindollar and Rebecca Sokol and Mark Sauer and Sean Tipton and Lynn Westphal",

note = "Publisher Copyright: {\textcopyright} 2016 American Society for Reproductive Medicine",

year = "2016",

month = dec,

day = "1",

doi = "10.1016/j.fertnstert.2016.08.038",

language = "English (US)",

volume = "106",

pages = "1627--1633",

journal = "Fertility and Sterility",

issn = "0015-0282",

publisher = "Elsevier Inc.",

number = "7",

}

TY - JOUR

T1 - Cross-border reproductive care

T2 - an Ethics Committee opinion

AU - Daar, Judith

AU - Benward, Jean

AU - Collins, Lee Rubin

AU - Davis, Joseph

AU - Franics, Leslie

AU - Gates, Elena

AU - Ginsburg, Elizabeth

AU - Klipstein, Sigal

AU - Koenig, Barbara

AU - McCullough, Laurence

AU - Reindollar, Richard

AU - Sokol, Rebecca

AU - Sauer, Mark

AU - Tipton, Sean

AU - Westphal, Lynn

PY - 2016/12/1

Y1 - 2016/12/1

N2 - Cross-border reproductive care (CBRC) is a growing worldwide phenomenon, raising questions about why assisted reproductive technology (ART) patients travel abroad, what harms and benefits may result, and what duties health-care providers may have in advising and treating patients who travel for reproductive services. Cross-border care offers benefits and poses harms to ART stakeholders, including patients, offspring, providers, gamete donors, gestational carriers, and local populations in destination countries. This document replaces the previous document of the same name, last published in 2013 (Fertil Steril 2013;100:645–50).

AB - Cross-border reproductive care (CBRC) is a growing worldwide phenomenon, raising questions about why assisted reproductive technology (ART) patients travel abroad, what harms and benefits may result, and what duties health-care providers may have in advising and treating patients who travel for reproductive services. Cross-border care offers benefits and poses harms to ART stakeholders, including patients, offspring, providers, gamete donors, gestational carriers, and local populations in destination countries. This document replaces the previous document of the same name, last published in 2013 (Fertil Steril 2013;100:645–50).

UR - http://www.scopus.com/inward/record.url?scp=84996520804&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84996520804&partnerID=8YFLogxK

U2 - 10.1016/j.fertnstert.2016.08.038

DO - 10.1016/j.fertnstert.2016.08.038

M3 - Article

C2 - 27678029

AN - SCOPUS:84996520804

SN - 0015-0282

VL - 106

SP - 1627

EP - 1633

JO - Fertility and Sterility

JF - Fertility and Sterility

IS - 7

ER -

Cross-border reproductive care: an Ethics Committee opinion

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this